Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering

Core Viewpoint - Sharps Technology, Inc. has successfully closed a public offering, raising approximately $20.0 million in gross proceeds before expenses [1]. Group 1: Offering Details - The offering included 14,285,714 Common Units, each comprising one share of Common Stock or one Pre-Funded Warrant, along with Series A and Series B Registered Common Warrants, both with an exercise price of$1.75 [2]. - The public offering price per Common Unit was set at $1.40, with Pre-Funded Units priced at$1.3999 [2]. - Aegis Capital Corp. was granted a 45-day option to purchase additional shares and warrants, with Aegis exercising this option for 2,142,857 Series A and Series B Warrants on the closing date [3]. Group 2: Company Background - Sharps Technology is an innovative medical device and pharmaceutical packaging company, focusing on patented smart-safety syringe products that emphasize ultra-low waste capabilities [6]. - The company operates a manufacturing facility in Hungary and is collaborating with Nephron Pharmaceuticals to enhance its manufacturing capacity in the U.S. [7].